KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Precigen (PGEN) EBT (2016 - 2025)

Historic EBT for Precigen (PGEN) over the last 14 years, with Q3 2025 value amounting to -$146.3 million.

  • Precigen's EBT fell 51063.17% to -$146.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$247.0 million, marking a year-over-year decrease of 7439.73%. This contributed to the annual value of -$128.0 million for FY2024, which is 3286.15% down from last year.
  • According to the latest figures from Q3 2025, Precigen's EBT is -$146.3 million, which was down 51063.17% from -$26.6 million recorded in Q2 2025.
  • Precigen's 5-year EBT high stood at -$7.7 million for Q3 2022, and its period low was -$146.3 million during Q3 2025.
  • Moreover, its 5-year median value for EBT was -$24.0 million (2024), whereas its average is -$33.6 million.
  • As far as peak fluctuations go, Precigen's EBT skyrocketed by 7083.4% in 2022, and later plummeted by 51063.17% in 2025.
  • Precigen's EBT (Quarter) stood at -$26.7 million in 2021, then rose by 16.93% to -$22.2 million in 2022, then tumbled by 50.61% to -$33.4 million in 2023, then surged by 40.66% to -$19.8 million in 2024, then tumbled by 638.59% to -$146.3 million in 2025.
  • Its EBT was -$146.3 million in Q3 2025, compared to -$26.6 million in Q2 2025 and -$54.2 million in Q1 2025.